San Carlos, CA, United States of America

Daniel P Sutherlin

USPTO Granted Patents = 55 (Patent Applications = 24)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 19 (Patent Applications = 28)

Average Co-Inventor Count = 7.4

ph-index = 10

Forward Citations = 337(Granted Patents)

Forward Citations (Not Self Cited) = 268(Dec 10, 2025)

Inventors with similar research interests:

Location History:

So. San Francisco, CA (US) (2007)
San Carlos, CA (US) (2002 - 2009)
Burlingame, CA (US) (2012 - 2017)
South San Francisco, CA (US) (2004 - 2021)

Company Filing History:

F. Hoffmann-la Roche Ag

patents

12 out of 109

Xenon Pharmaceuticals Inc.

Hoffmann-la Roche Inc.

where one patent can have more than one assignee

Years Active: 2002-2021

Loading Chart...

Areas of Expertise:

Substituted Benzamides

Therapeutic Compounds

Sodium Channel Inhibitors

Phosphoinositide 3-Kinase Inhibitors

Hedgehog Signalling Inhibitors

Benzopyran Compounds

Pyrazolopyrimidine Inhibitors

Purine Compounds

Bicyclic Pyrimidine Inhibitors

Fibroblast Activation Protein Inhibitors

Integrin Receptor Inhibitors

Pharmaceutical Compounds

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203572 - Substituted benzamides and methods of use thereof (2021-12-21),

2. 11130726 - Therapeutic compounds and methods of use thereof (2021-09-28),

3. 11028075 - Therapeutic compounds and methods of use thereof (2021-06-08),

4. 10793550 - 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors (2020-10-06),

5. 10787446 - Therapeutic compounds and methods of use thereof (2020-09-29),

6. 10766858 - Substituted benzamides and methods of use thereof (2020-09-08),

7. 10457654 - Therapeutic compounds and methods of use thereof (2019-10-29),

8. 10179767 - Substituted benzamides and methods of use thereof (2019-01-15),

9. 10071957 - N-substituted benzamides and methods of use thereof (2018-09-11),

10. 9943519 - Pharmaceutical compounds (2018-04-17),

11. 9790183 - Pyridyl inhibitors of hedgehog signalling (2017-10-17),

12. 9771376 - N-substituted benzamides and methods of use thereof (2017-09-26),

13. 9694002 - Substituted benzamides and methods of use thereof (2017-07-04),

14. 9546164 - Substituted benzamides and methods of use thereof (2017-01-17),

15. 9487533 - Phosphoinositide 3-kinase inhibitor compounds and methods of use (2016-11-08),

Title: The Innovative Journey of Daniel P Sutherlin

Introduction: Daniel P Sutherlin is a renowned inventor based in San Carlos, CA (US) known for his groundbreaking contributions to various industries.

Latest Patents: Daniel P Sutherlin holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Daniel has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Daniel has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life, resulting in successful products that have had a significant impact on society.

Conclusion: Daniel P Sutherlin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.